CVS HEALTH Corp (CVS) — Q2 2025 13F-HR

← CVS HEALTH Corp (CVS)

Q2 2025 · 13F-HR

CVS HEALTH Corp (CVS)holdings as filed

Filed 2025-08-01 · accession 0000950123-25-006907

$190.6M

Reported value

Positions

2025-06-30

Period end

View analyzed profile →PRO

The Brief · CVS HEALTH Corp (CVS) · Q2 2025

AI · grounded in 13F

CVS HEALTH Corp (CVS) established a new position in SPY valued at $190.2M. The fund also added new holdings in PRU for $288,262 and HCAT for $121,667. These three positions bring the total assets under management to $190.6M.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
78462F103	SPY	SPDR S&P 500 ETF TR	$190.2M	99.8%	307,891	Common	SOLE
744320102	PRU	PRUDENTIAL FINL INC	$288,262	0.15%	2,683	Common	SOLE
42225T107	HCAT	HEALTH CATALYST INC	$121,667	0.06%	32,273	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.